Psoriasis

PHILADELPHIA — While over half of referrals generated by results from a home-screening survey for psoriatic arthritis were deemed appropriate, the rate of an actual diagnosis was low, according to results of a study.

FDA approvals led this year’s most read psoriasis articles on Healio.

Arcutis Biotherapeutics announced positive results from two pivotal phase 3 studies evaluating Zoryve cream as a once daily, topic treatment for chronic plaque psoriasis, according to a company press release.

UCB has resubmitted its biologics license application to the FDA for bimekizumab for the treatment of adults with moderate to severe plaque psoriasis, according to a company press release.

Smoking and obesity-related factors are significantly associated with an increased risk for psoriasis, according to a study.

Healio has launched a new point-of-care tool with modules on medical conditions to help clinicians treat patients using reliable information.

As severity of psoriasis increases, so does the risk of severe and rare infections, according to a population-based cohort study.

Guselkumab performed comparably in a real-world study of patients with moderate to severe plaque psoriasis as it had in previous clinical trials, according to study findings.

It is crucial that patients with juvenile arthritis stay active throughout their childhood for a better chance at building stronger bones, according to DMOS Orthopaedic Centers.

Inflammatory bowel disease was found to have a positive association with both psoriasis and psoriatic arthritis, suggesting it is a causal risk factor for these two chronic diseases, according to a study.